Molecular docking analysis of KRAS inhibitors for cancer management

The majority of human tumors are characterized by abnormal signaling caused by oncogenic RAS proteins. KRAS is a member of the RAS family and is currently one of the most thoroughly researched targets for cancer treatment due to its prevalence in a variety of deadly malignancies. Targeting the KRAS...

Descripción completa

Detalles Bibliográficos
Autores principales: J. Hakeem, Israa, Alsharif, Fatmah Hazza, Aljadani, Majidah, Fahad Alabbas, Ibrahim, Faqihi, Mohammed Saud, Aloufi, Ahmed Hamdan, Almutairi, Wael Abdullah, Akber, Asif Hussain, Alam, Qamre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563554/
https://www.ncbi.nlm.nih.gov/pubmed/37822837
http://dx.doi.org/10.6026/97320630019411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563554/
https://www.ncbi.nlm.nih.gov/pubmed/37822837
http://dx.doi.org/10.6026/97320630019411

Ejemplares similares